CHP2 p.Leu195Val
c.583C>G · VCV4002489
Computational evidence
| Protein change | ||
| AlphaMissense | 0.3262 | likely benign |
|---|---|---|
| REVEL | 0.668 | pathogenic-leaning |
| SaProt | LLR -9.94 | tolerated |
| ⇒ REVEL calls this damaging; AlphaMissense and SaProt do not. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 2.6 | GERP 1.4, phastCons 1 |
| Regional constraint | o/e 1.22 | unconstrained · MANE · 2,530 bp · p 0.00038 · regional, not allelic |
| Overall | ||
| CADD | 21.5 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| European (non-Finnish)grpmax | 0.00186% | 53,635 |
| Admixed American | 0.00167% | 59,992 |
| African / African-American | 0.00134% | 74,894 |
| South Asian | 0.0011% | 91,080 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CHP2
- Protein
- p.Leu195Val
- Coding
- c.583C>G
- MANE Select
- NM_022097
- Type
- single nucleotide variant
- Location
- chr16:23757575 (GRCh38)
- Gene constraint
- LOEUF 1.653 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 86.86 · 1 PDB
- Residue 195
- a turn
Similar variants
- CHP2 p.Ala37Thr Uncertain significance ★ ⚠ same type
- CHP2 p.Arg127His Uncertain significance ★ ⚠ same type
- CHP2 p.Arg159Cys Uncertain significance ★ ⚠ same type
- CHP2 p.Arg159His Uncertain significance ★ ⚠ same type
- CHP2 p.Arg193Gly Uncertain significance ★ ⚠ same type
- CHP2 p.Arg30Cys Uncertain significance ★ ⚠ same type
- CHP2 p.Arg30His Uncertain significance ★ ⚠ same type
- CHP2 p.Arg36Trp Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/chp2-p-leu195val (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown